Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Oncologix Tech Inc. | oclg10q05312015ex31_1.htm |
| EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - Oncologix Tech Inc. | oclg10q05312015ex31_2.htm |
| EX-32.2 - ONCOLOGIX TECH, INC. AND SUBSIDIARIES - Oncologix Tech Inc. | oclg10q05312015ex32_2.htm |
| 10-Q - OCLG10Q05312015 - Oncologix Tech Inc. | oclg10q05312015.htm |
Exhibit 32.1
ONCOLOGIX TECH, INC. AND SUBSIDIARIES
CERTIFICATION OF PRINCIPAL
EXECUTIVE OFFICER PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Oncologix Tech, Inc. (the “Company”) on Form 10-Q for the three months ended May 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I Roy Wayne Erwin, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
/s/ Roy Wayne Erwin
Roy Wayne Erwin
Chief Executive Officer and President
July 17, 2015